Abstract
Abbreviations and Acronyms:
BMI (body mass index), CDC (Centers for Disease Control and Prevention), CHC (combined hormonal contraceptives), COC (combined oral contraceptives), CVA (cerebral vascular event), DMPA (depot medroxyprogesterone acetate), EIN (endometrial intraepithelial neoplasia), IUC (intrauterine contraception), IUD (intrauterine device), IUS (intrauterine contraceptive system), LARC (long-acting reversible contraception), LNG (levonorgestrel), MI (myocardial infarction), POP (progestin only pill), STI (sexually transmitted infection), USMEC (United States Medical Eligibility Criteria for Contraceptive Use), USSPR (US Selected Practice Recommendations for Contraceptive Use), VTE (venous thromboembolism)- 1.Read the activity.
- 2.Complete the online CME Test and Evaluation. Participants must achieve a score of 80% on the CME Test. One retake is allowed.
Timely Issues in Contraception
Current Contraceptive Use
Common Medical Conditions
Cardiac Disease/Hypertension/Diabetes
Venous Thromboembolism
Anticoagulation/Bleeding Diathesis
Liver Disease
Inflammatory Bowel Disease
Common Connective Tissue Diseases
National Institutes of Health. Autoimmune Diseases of Rheumatoid Arthritis and Lupus. https://www.nih.gov/research-training/accelerating-medicines-partnership-amp/autoimmune-diseases-rheumatoid-arthritis-lupus. Accessed October 21, 2020.
Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome
Sexually Transmitted Diseases/Infections/Pelvic Inflammatory Disease
Solid Organ Transplant(s)/Immunosuppression
Obesity
- Morelli M.
- Di Cello A.
- Venturella R.
- Mocciaro R.
- D’Alessandro P.
- Zullo F.
Migraines
Seizures and Anticonvulsants
Post Abortion
Thyroid Disease
Multiple Sclerosis
Cervical Cancer
Endometrial Cancer/Endometrial Hyperplasia or Endometrial Intraepithelial Neoplasia
- Morelli M.
- Di Cello A.
- Venturella R.
- Mocciaro R.
- D’Alessandro P.
- Zullo F.
- Morelli M.
- Di Cello A.
- Venturella R.
- Mocciaro R.
- D’Alessandro P.
- Zullo F.
Gestational Trophoblastic Disease
Ovarian Cancer
Breast Cancer
Summary
Conclusion
References
- US medical eligibility criteria for contraceptive use.MMWR Recomm Rep. 2016; 65: 1-103
- US selected practice recommendations for contraceptive use, 2016.MMWR Recomm Rep. 2016; 65: 1-66
- Update: providing quality family planning services – recommendations from CDC and the US Office of Population Affairs, 2017.MMWR Morb Mortal Wkly Rep. 2017; 66: 1383-1385
- Changes in US health care provider attitudes related to contraceptive safety before and after the release of national guidance.Contraception. 2019; 100: 413-419
- Postpartum hormonal contraception use and incidence of postpartum depression: a systematic review.Eur J Contracept Reprod Health Care. 2019; 24: 109-116
- Combined hormonal contraceptive (CHC) use among obese women and contraceptive effectiveness: a systemic review.Contraception. 2017; 95: 117-129
- Contraception strategies in women with heart failure or with cardiac transplantation.Curr H Failure Rep. 2018; 15: 161-170
- A systemic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.Int J Gynaecol Obstet. 2018; 141: 287-294
- Factors associated with provision of depo medroxyprogesterone acetate to adolescents by US health care providers.Contraception. 2019; 99: 300-305
- Safety and effectiveness of hormonal contraception for women who use opioids: a systematic review.Contraception. 2019; 100: 480-483
- Drug interactions between non-rifamycina antibiotics and hormone contraception: a systemic review.Am J Obstet Gynecol. 2018; 218: 88-97.e14
- Practice Bulletin No. 186: Long-acting reversible contraception: implants and intrauterine devices.Obstet Gynecol. 2017; 130: e251-e269
- Factors associated with postpartum use of long-acting reversible contraception.Am J Obstet Gynecol. 2019; 221: 43e1-4343.e11
- NCHS Data Brief, No. 327, Dec 2018.(Accessed May 29, 2020)
- National Center for Health Statistics and Prevalence of Disease, Data and Statistics.https://www.cdc.govDate accessed: May , 2020
- Contraception in perimenopausal women with diabetes mellitus.Gynecol Endocrinol. 2006; 22: 198-206
- Risk of arterial thrombosis in relation to oral contraceptives (RATIO) study: oral contraceptives and risk of ischemic stroke.Stroke. 2002; 33: 1202-1208
- Oral contraceptives use and the risk of myocardial infarction: a meta-analysis.Contraception. 2002; 68: 11-17
- Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes.Obstet Gynecol. 2014; 124: 600-609
- Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up.Contraception. 2011; 83: 242-247
- Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use.Blood. 2016; 127: 1417-1425
- Progestin-only contraceptive use among women with sickle anemia: a systematic review.Contraception. 2006; 73: 195-204
- Exposure to oral contraceptives increases the risk for development of inflammatory bowel disease: a meta-analysis of case-controlled and cohort studies.Eur J Gastroenterol Hepatol. 2017; 29: 1064-1070
National Institutes of Health. Autoimmune Diseases of Rheumatoid Arthritis and Lupus. https://www.nih.gov/research-training/accelerating-medicines-partnership-amp/autoimmune-diseases-rheumatoid-arthritis-lupus. Accessed October 21, 2020.
- ACOG Practice Bulletin No. 206: use of hormonal contraception in women with coexisting medical conditions.Obstet Gynecol. 2019; 133: e128-150
- Update to US medical eligibility criteria for contraceptive US, 2016: updated recommendations for the use of contraception among women at high risk for HIV infection.MMWR Morb Mortal Wkly Rep. 2020; 69: 405-410
- The levonorgestrel-releasing intrauterine system in human immunodeficiency virus-infected women: a 5-year follow-up study.Am J Obstet Gynecol. 2011; 204: 126.e1-126.e4
- 2018 STD Surveillance Report.www.cdc.govDate accessed: May , 2020
- Using an intrauterine device in immunocompromised women.Obstet Gynecol. 2008; 112: 667-669
- Use of levonorgestrel 52-mg intrauterine system in adolescent and young adult solid organ transplant recipients: a case series.Contraception. 2017; 95: 378-381
- Hormonal contraceptives for contraception in overweight or obese women.Cochrane Database Syst Rev. 2016; 8: CD008452
- Correcting oral contraceptive pharmacokinetic alterations due to obesity: a randomized controlled trial.Contraception. 2014; 90 (2014): 550-556
- Efficacy of the levonorgestrel intrauterine system (LNG IUS) in the prevention of atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women.Gynecol Endocrinol. 2013; 29 (2013): 156-159
- ACOG Practice Bulletin No. 105: Bariatric surgery and pregnancy.Obstet Gynecol. 2009; 113: 1405-1413
- AMPP advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy.Neurology. 2007; 68: 343-349
- Headache Classification Committee of the International Headache Society (HIS) the International Classification of Headache Disorders, 3rd edition.Cephalalgia. 2018; 38: 1-211
- Safety of hormonal contraceptives among women with migraine: a systemic review.Contraception. 2016; 94 (2016): 630-640
- Hormonal contraception and migraine: clinical considerations.Perimenstrual Headache. 2012; 16: 461-466
- Observational series on women using the contraceptive Mirena concurrently with antiepileptic and other enzyme-inducing drugs.J Fam Plann Reprod Health Care. 2002; 28: 78-80
- Contraception for Women With Epilepsy.in: Allen R.H. Cwiak C.A. Contraception for the medically challenging patient. Springer, New York, NY2014: 135-136
- The use of hormonal contraception among women taking anticonvulsant therapy.Contraception. 2011; 83: 16-29
- Etonogestrel (Implanon), another treatment option for contraception.P T. 2008; 33: 337-347
- Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer.Front Pharmacol. 2015; 242: 1-11
- Cervical cancer and use of hormonal contraceptives: a systematic review.Lancet. 2003; 361: 1159-1167
- Intrauterine device use and cervical cancer risk: a systematic review and meta-analysis.Obstet Gynecol. 2017; 130: 1226-1236
- The Pill’s gestation: from birth control to cancer prevention.Lancet Oncol. 2015; 16: 1004-1006
- Intrauterine device use and ovarian cancer risk: a systematic review and meta-analysis.Obstet Gynecol. 2019; 134: 791-800
- Use of oral contraceptives in BRCA mutation carriers and risk for ovarian cancer: a systematic review.Arch Gynecol Obstet. 2020; 301: 875-884
Article Info
Footnotes
Potential Competing Interests: The authors report no potential competing interests.